Co-Diagnostics JV reports HPV study finds high-grade lesions or cancer in 12 of 20 HPV-positive women
CODX•A study using CoSara Diagnostics’ SARAGENE high-risk HPV test found high-grade cervical lesions or invasive cancer in 12 of 20 HPV-positive women. Investigators called the findings preliminary and said larger studies are needed to confirm them.
1. Study findings
Follow-up biopsies identified high-grade cervical lesions or invasive cervical cancer in 12 of 20 HPV-positive women, despite predominantly negative cytology results. Investigators described the findings as preliminary, citing the study design and limited number of HPV-positive participants; the laboratory-based test is authorized in India but not available for sale in the United States.
